“It’s the end of free money and we think it’s a good thing.” Oppenheimer Asset Management's Chief Investment Strategist, John Stoltzfus gives his thoughts on the current interest rate environment. Click here for his full mid-year market update: https://lnkd.in/epQ73HGV #ThePowerofOppenheimerThinking
Oppenheimer & Co. Inc.
Financial Services
New York, NY 59,973 followers
Oppenheimer provides a full range of wealth management, securities brokerage, and investment banking services.
About us
Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions. We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking. Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer.
- Website
-
http://www.oppenheimer.com
External link for Oppenheimer & Co. Inc.
- Industry
- Financial Services
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, NY
- Type
- Public Company
- Founded
- 1881
- Specialties
- Wealth Management, Debt and Equity Capital Markets, Mergers & Acquisitions, Retirement Services, Asset Management, Investment Banking, and Equity Research
Locations
Employees at Oppenheimer & Co. Inc.
Updates
-
We are pleased to welcome Andreas Argyrides as Executive Director and Senior Analyst covering the Biotechnology sector. Andreas has more than 15 years of financial industry experience. His expertise includes coverage of companies engaged in the development of new therapies for eye, liver, and lung diseases as well as gene therapies for rare genomic diseases.
-
We are pleased to have acted as Sole Dealer Manager to TriSalus Life Sciences, Inc. on its Public Warrant Exchange of 7.0 Million Warrants.
Sole Dealer Manager to TriSalus Life Sciences, Inc.
oppenheimer.com
-
Oppenheimer has appointed Rayna Kumar as Managing Director and Senior Analyst for the Fintech sector. Leading a four-person team from our New York office, Rayna brings extensive expertise in the payments ecosystem, from card networks to AI in finance. Welcome aboard, Rayna! 🚀 #Fintech #Leadership #ThePowerofOppenheimerThinking https://lnkd.in/eTzUYBXZ
Oppenheimer Appoints Rayna Kumar as Managing Director and Senior Analyst Covering the Fintech Sector
oppenheimer.com
-
We are pleased to have acted as Lead Bookrunner and Structuring Agent for Sound Point Meridian Capital, Inc. (NYSE: SPMC) on its $80.0M Initial Public Offering.
Lead Bookrunner and Structuring Agent on Sound Point Meridian Capital, Inc.'s Initial Public Offering
oppenheimer.com
-
Oppenheimer recently hosted a successful workshop with EnVent Capital Markets in Milan. During the event, we explored trends and opportunities in the European corporate credit markets, particularly in the middle market space. The evening was made even more special with a fantastic dinner prepared by the renowned chef Gennaro Esposito. It was a pleasure to hear from Marcello Bragliani, partner at Latham & Watkins, and Sandro Patti, CIO and founder of Valiant Asset Management, as they shared their insights with the investing community. #ThePowerofOppenheimerThinking Max Lami
-
-
We are pleased to have acted as Exclusive Financial Advisor to Merit Medical Systems, Inc. on its $105 million asset purchase of EndoGastric Solutions, Inc.
Exclusive Financial Advisor to Merit Medical Systems, Inc. on its Asset Purchase of EndoGastric Solutions, Inc.
oppenheimer.com
-
In our view it is not uncommon in early bull markets for one or just a few sectors to gain traction and lead market performance before a broadening in performance takes hold.
Churn, Churn, Churn | 07/01/2024 Market Strategy
oppenheimer.com